Last updated 2026-06-18
- Acquired by Texas Instruments, Jan 1999
- Raised funding round, Jan 1997
Total raised
—
Last: 1997-01
Stage
Acquired
Founded
1992
Headcount
31
HQ
Herzliya, Israel
Sector
—
About
Butterfly VLSI supplies integrated silicon solutions for cable broadband access and wireless LAN markets in the home and small office environments. The company primarily focused on research and development activities related to RF wireless technology.
Funding history · 1 round · — total
1997-01
Undisclosed
Q&A
- What is Butterfly VLSI's primary focus?
- Butterfly VLSI supplies integrated silicon solutions for cable broadband access and wireless LAN markets, with a primary focus on research and development activities related to RF wireless technology.
- When was Butterfly VLSI founded?
- Butterfly VLSI was founded in January 1992.
- What is the current status of Butterfly VLSI?
- Butterfly VLSI was acquired by Texas Instruments in January 1999 and is currently inactive.
- How many employees did Butterfly VLSI have?
- Butterfly VLSI had 11-50 employees.
- Where is Butterfly VLSI headquartered?
- Butterfly VLSI is headquartered in Herzliya, Center District, Israel.
- Which investor participated in Butterfly VLSI's funding round?
- S Capital VC participated in Butterfly VLSI's funding round in January 1997.
- What business model does Butterfly VLSI employ?
- Butterfly VLSI operates on a B2B (business-to-business) model.
- What technologies are associated with Butterfly VLSI?
- Butterfly VLSI is associated with semiconductors, wireless communication, and chips design.
Sectors & technology
Business model
B2B
Tags
semiconductorswireless-communicationchips-design
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 1992-1 |
|---|---|
| Employees (exact) | 31 |
| Status reason | Acquired (Inactive) by Texas Instruments on Jan 1999 - closed due to acquisition |
Acquisitions & public offerings
Acquired by Texas Instruments 1999-01
Radar intelligence
Patents
| EPO | 1 |
|---|